Category: Mass Spectrometry

Mass Spectrometry

The collaboration focuses on creating sensitive assays for a common genetic risk factor to guide drug development and clinical trials.

Callisto system now supports seven validated DNA library preparation workflows across multiple sequencing platforms and chemistries.

Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.

Researchers develop computational approach to predict mass spectra for unknown psychoactive substances and their metabolites.

This collaboration aims to advance a smartphone-based hemoglobin test for accessible diagnostics of anemia and other health conditions.

Researchers have developed a blood-based proteomics model that accurately predicts disease progression in ADPKD.